Purchase Order 75N98023P02768

Award Date 8/31/23
Potential Completion Date 8/30/24
Potential Value $30K
Ultimate Awardee
Qiagen N.V.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,064 purchase order to Qiagen, LLC. Under this firm fixed price contract, Qiagen will provide products or services to the NIH Clinical Center in Germantown, Maryland between September 2023 and September 2024. As a division of Qiagen N.V., Qiagen, LLC will leverage its parent company's expertise in sample and assay technologies to support the NIH Clinical Center's biomedical research and...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,433 firm fixed price purchase order to Qiagen, LLC for unspecified products or services. Qiagen, a subsidiary of Qiagen N.V., will perform the contract from its location in Bethesda, Maryland over a one year period ending August 2024. No additional details were provided regarding the original solicitation or scope of work. However, based on the funding agency, the products or services are...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $11,449.80 firm fixed price purchase order to Qiagen, LLC for the performance of clinical testing in the molecular diagnostics laboratory of the microbiology service. Qiagen will provide products and services to support the required testing through March 2024. No set-aside designation was applied to this award. Qiagen is an international provider of sample and assay technologies for molecular...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $37,877 purchase order to Qiagen, LLC for reagents and consumables. Qiagen, a division of Qiagen N.V., will provide the requested products to the agency in Germantown, Maryland over a two month period under a firm fixed price contract. No additional details were provided on the original solicitation, major subcontractors, or high-level context regarding the funding agency's programs. The award...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $10,037.40 contract will provide the NIH with Qiagen's sample and assay technologies to support the agency's biomedical research, public health, and healthcare programs. The contract does not have a set-aside designation. Qiagen has a history of providing a range of products and services to federal...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $13,576.68 firm fixed price call against a Blanket Purchase Agreement to Qiagen, LLC for chemicals. The place of performance is Valencia, California and the period of performance runs through April 30, 2024. No set-aside provisions were specified. As the awarding agency, NIH likely requires chemicals in support of biomedical research activities across its various...
This is a $80,260 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The contract is not set aside and has a period of performance from March 28, 2019 to April 14, 2021. Qiagen, a global provider of sample and assay technologies, has delivered a range of products and services to federal agencies, including DNA/RNA extraction kits, next-generation sequencing equipment, bioinformatics software, and other...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded Qiagen, LLC a $10,139.80 firm fixed price purchase order for REAGENTS-QIASEQ TARGETED DNA CUSTOM PANEL (96)-6601-6700. Qiagen will provide the requested targeted DNA custom panel reagents to the NIH Clinical Center in Bethesda, Maryland by July 26, 2023. As the prime contractor, Qiagen will self-perform this contract without the use of major subcontractors. The award utilizes a standard firm fixed...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The $111,768.00 contract does not have a set-aside designation. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, is delivering products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen holds several...

The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $30,468 firm fixed price purchase order to Qiagen, LLC. Qiagen will provide products and services to NIH under the contract, which runs from August 2023 through August 2024. Qiagen is a subsidiary of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. The place of performance is Bethesda, Maryland, where several NIH facilities are located. No subcontractors or set aside designations were identified. The award will likely support NIH's ongoing biomedical research efforts through the provision of Qiagen's products and services.

Generated 12/24/23, 10:27 PM